Press release
Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn Over 2022 || Key Player: AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC
Medical institutions across the world are ramping up their efforts towards the development of effective therapeutic drugs for cancer treatment. In addition to this, investors are underpinning the initiatives of healthcare organizations by funding their researches. With the report produced by the World Health Organization (WHO) stating the occurrence of over 8 Mn deaths in 2015 backed by the pervasiveness of cancer, proliferating adoption of advanced peptide based cancer therapeutic is witnessed. A host of these factors have contributed to the growing size of the peptide-based cancer therapeutics market at the global level with an estimated CAGR of over 9% through 2022.
Get Free Sample Report Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=179
North America enjoys a large concentration of peptide based cancer therapeutic drug manufacturers, which has reflected positively on the growth of this market. Additionally, the advanced healthcare infrastructures have also been a driving factor fostering the growth of this market.
On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.
Peptide Based Cancer Therapeutics Market: Synopsis of the Report
The primary aim of this market study on peptide-based cancer therapeutics is to lend a holistic view of the market to the stakeholders. The forecast has been done for the period from 2017 to 2022. Here, 2017 is considered as the base year and prediction has been provided for the duration 2018 to 2022. The market evaluation has been done in revenue (US$ Mn).
The report commences with a detailed executive summary, which further provides the scope of the study. An analysis of the year-over-year growth is incorporated in the study, with a view to providing information on the growth patterns of the market. In the succeeding section of the report, macroeconomic and microeconomic factors influencing the market growth has been discussed and included. The report delineates demand drivers, opportunities, threats, restraints and challenging, impacting the market at the global level. A segment-wise analysis is also included in the report, in order to lend a decisive view of the market to the stakeholders.
Browse Full Report with ToC Here:
https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market
An analysis of the supply chain and average pricing is discussed in the report to understand the dynamics of the peptide-based cancer therapeutics market. Evaluation of the attractiveness of the market has been carried out on the basis of region, drug, and distribution channel.
Outline of Dominant Competitors and Geographies Influencing the Growth of the Peptide-based Cancer Therapeutics Market
The regions analyzed in the report consist of Latin America, North America, Europe, Japan, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). The regions have been analyzed keeping the segments – drug and distribution channel and their revenue share to the global market in mind.
The leading companies profiled in this market study includes Allergan plc, Valeant Pharmaceuticals International, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Johnson & Johnson, and Abbott, Pfizer Inc. An in-depth company overview, business strategies, market size, and recent developments are discussed in this report. These insights incorporated in the report will aid the drug manufacturers, raw material distributors, and research institutes in devising informed strategies to capture a large market share.
Have Any Query?? Ask Our Industry Expert
https://www.factmr.com/connectus/sample?flag=AE&rep_id=179
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
sales@factmr.com
www.factmr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn Over 2022 || Key Player: AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC here
News-ID: 1688016 • Views: …
More Releases from Fact.MR
Body Area Network Market Forecasted to Expand Rapidly, Projecting US$ 229.8 Bill …
It is anticipated that the worldwide body area network market will expand at a strong 22.3% CAGR. Its anticipated value increased from US$ 24.6 billion in 2021 to around US$ 229.8 billion by 2032.
A new generation of body-attachable wireless body sensors has emerged in response to advancements in wireless communication technology and various physiological sensor types.
Download a Sample Copy Of Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7208
Body Area Networks, or BANs, are becoming a game-changer…
Payroll Outsourcing Services Market Is Likely To Be Valued At US$ 32607.5 Millio …
The global payroll outsourcing services market was valued at US$ 17000 Million in 2022. During the 2023-2033 period of assessment, demand is expected to rise at a 6.1% value CAGR, likely to surpass a valuation of US$ 32607.5 Million by the end of the said forecast period.
The Payroll Outsourcing Services Industry sales study offers a comprehensive analysis on diverse features including production capacities, Payroll Outsourcing Services demand, product developments, sales…
Carotenoids Market Is Forecasted To Reach US$ 2.45 Billion at 5.4% CAGR By 2034: …
With an estimated market size of US$ 1.45 billion in 2024, the global carotenoid market is projected to expand at a CAGR of 5.4% and reach a market value of US$ 2.45 billion by 2034-end. Growth prospects of the market remain optimistic, owing to shifting consumer preferences for natural ingredients, expanding carotenoid applications in a range of industries, and ongoing developments in product development and formulation techniques.
The Carotenoid Industry sales…
Canned Fruits Market Is Anticipated To Reach A Valuation Of US$ 12 Billion By 20 …
The value of the global canned fruits market is US$ 9.8 billion in 2022, which is projected to climb to US$ 12 billion by 2032-end, increasing at a CAGR of 2% through 2032.
The Canned Fruits Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Fruits demand, product developments, sales revenue generation and Canned Fruits market outlook across the globe.
market research report by Fact.MR, (Leading business…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…
